The current state of precision medicine and how it could soon help doctors predict diseases before the onset of symptoms.
No matter how you look at it, the toll of diabetes and prediabetes is staggering whether you’re the patient, the primary care physician, the employer or the health plan.
To get a pulse on the U.S.
Douglas Long, vice president of industry relations at Durham, NC-based IQVIA, a newly named company after the merger of IMS Health and Quintiles, discussed pharmaceutical marketplace trends during the headline session at the Academy of Ma
A diabetes patient’s ambivalence about changing their diet or taking their insulin can stand between successful management of their disease and a further escalation that could lead to blindness, limb removal, or even death.
Payers are stepping up efforts to manage the cost and utilization of orphan drug treatments.
The cost to treat cancer in the United States could reach $156 billion in 2020, according to the National Cancer Institute. And innovative medications have a significant impact on the cost of care.
A new study has exciting findings about costs and hospital admissions for Medicare and Medicaid beneficiaries participating in certain food delivery programs.
Gene therapy, which got its start in the 1960s, is finally starting to take hold.
Expiring patents and biosimilar developments are creating big market opportunities within the specialty drug space.